Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
11 clinical trials · Condition
◉ Watch Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. (NCT04882462) | The First Affiliated Hospital of Soochow University | 2021-05-01 |
| Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX) (NCT04282109) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2020-06-03 |
Track Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.